Eom Tae-Yoon, Choi Ju-Won, Yoon Kyong-Ah, Jeong Soon-Wuk, Kim Jung-Hyun
Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University, Seoul, South Korea.
Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul, South Korea.
Front Vet Sci. 2021 Nov 25;8:795928. doi: 10.3389/fvets.2021.795928. eCollection 2021.
A 16-year-old spayed female Pomeranian dog was presented to the hospital with an acute onset of pain and non-weight-bearing lameness in the right forelimb. On physical examination, knuckling, coolness, pain, and cyanosis were observed in the affected forelimb. Peripheral blood glucose concentration and body surface temperature differed between the right and left forelimbs. Hypercoagulable thromboelastographic results and increased D-dimer levels were suggestive of thrombus. Accordingly, recombinant tissue plasminogen activator (rtPA) was administered intravenously. Prompt clinical improvements (including restored warmth of the affected limb) occurred, and rtPA was discontinued after two shots administered 2 h apart owing to concerns of bleeding side effects. The dog was discharged 6 days after admission, and outpatient treatment with clopidogrel was continued for the prevention of re-thrombosis. Following patient stabilization, further examinations for underlying diseases of hypercoagulability were conducted; hyperadrenocorticism (HAC) was diagnosed, and oral trilostane therapy was thus administered. Eight weeks later, the patient regained normal mobility. Finally, in the present canine patient with arterial thrombosis, thrombolysis with rtPA successfully improved clinical symptoms and the following administration of clopidogrel inhibited the formation of additional thrombus.
一只16岁已绝育的雌性博美犬因右前肢突发疼痛和非负重性跛行被送至医院。体格检查时,发现患侧前肢有指关节屈曲、发凉、疼痛和发绀。左右前肢的外周血糖浓度和体表温度存在差异。血栓弹力图显示高凝状态且D - 二聚体水平升高提示有血栓形成。因此,静脉注射重组组织型纤溶酶原激活剂(rtPA)。临床症状迅速改善(包括患肢恢复温暖),由于担心出血副作用,在相隔2小时注射两针后停用rtPA。入院6天后该犬出院,继续口服氯吡格雷进行门诊治疗以预防再次血栓形成。在患者病情稳定后,对高凝状态的潜在疾病进行了进一步检查;诊断为肾上腺皮质功能亢进(HAC),因此给予口服曲洛司坦治疗。八周后,患者恢复了正常活动能力。最后,在这例患有动脉血栓形成的犬类患者中,rtPA溶栓成功改善了临床症状,随后给予氯吡格雷抑制了额外血栓的形成。